We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
T2 Biosystems Inc | NASDAQ:TTOO | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.07 | 2.55% | 2.81 | 2.75 | 2.90 | 2.9353 | 2.7001 | 2.76 | 140,888 | 00:58:35 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM SD
Specialized Disclosure Report
T2 BIOSYSTEMS, INC.
(Exact name of Registrant as specified in charter)
Delaware | 001-36571 | 20-4827488 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I. R. S. Employer Identification No.) |
101 Hartwell Ave., Lexington, MA 02421
(Address of principal executive offices)
Michael Gibbs, General Counsel, (781) 761-4630
(Name and telephone number, including area code, of person to contact in connection with this report)
Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:
☒ |
Rule 13p-1 under the Securities Exchange Act (17 CFR 2401.13p-1) for the reporting period from January 1 to December 31, 2018 |
Section 1 Conflict Minerals Disclosure
Item 1.01 |
Conflict Minerals Disclosure and Report |
Conflict Minerals Disclosure
This Form SD of T2 Biosystems, Inc. (the Company) is filed pursuant to Rule 13p-1 promulgated under the Securities Exchange Act of 1934 for the reporting period January 1, 2018 to December 31, 2018.
A copy of the Companys Conflict Minerals Report is provided as Exhibit 1.01 to this Form SD, and is publicly available at www.t2biosystems.com.
Item 1.02 |
Exhibit |
As specified in Section 2, Item 2.01 of this Form SD, the Company is hereby filing its Conflict Minerals Report as Exhibit 1.01 to this report.
Section 2 Exhibits
Item 2.01 |
Exhibits |
Exhibit
No. |
Description |
|
1.01 | Conflict Minerals Report of T2 Biosystems, Inc. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: May 31, 2019 | T2 BIOSYSTEMS, INC. | |||||
By: | /s/ John McDonough | |||||
John McDonough | ||||||
President and Chief Executive Officer |
EXHIBIT INDEX
Exhibit
No. |
Description |
|
1.01 | Conflict Minerals Report of T2 Biosystems, Inc. |
1 Year T2 Biosystems Chart |
1 Month T2 Biosystems Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions